Herpesviridae Infections  >>  inactivated VZV vaccine (V212)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
inactivated VZV vaccine (V212) / Merck (MSD)
NCT00886613: A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)

Completed
1
120
US
V212, Comparator: Zostavax™, V211 (Zoster Vaccine Live (Oka/Merck)), Comparator: Placebo, VZV Skin Test, Saline
Merck Sharp & Dohme LLC
Herpes Zoster
12/09
12/09
NCT01460719: A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013)

Completed
1
80
NA
V212, Inactivated Varicella-Zoster (VZV) vaccine
Merck Sharp & Dohme LLC
Herpes Zoster
09/12
09/12

Download Options